RGEN logo

RGEN
Repligen Corp.

1,553
Mkt Cap
$6.63B
Volume
797,307.00
52W High
$175.77
52W Low
$102.97
PE Ratio
136.26
RGEN Fundamentals
Price
$117.78
Prev Close
$118.32
Open
$114.20
50D MA
$131.89
Beta
1.46
Avg. Volume
922,458.40
EPS (Annual)
$0.8644
P/B
3.15
Rev/Employee
$369,128.00
$9,190.41
Loading...
Loading...
News
all
press releases
Are Options Traders Betting on a Big Move in Repligen Stock?
Investors need to pay close attention to RGEN stock based on the movements in the options market lately.
Zacks·2d ago
News Placeholder
More News
News Placeholder
Riverbridge Partners LLC Sells 30,070 Shares of Repligen Corporation $RGEN
Riverbridge Partners LLC reduced its position in Repligen Corporation (NASDAQ:RGEN - Free Report) by 8.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 313,365 shares of the biotechn...
MarketBeat·8d ago
News Placeholder
Repligen (RGEN) Down 13.5% Since Last Earnings Report: Can It Rebound?
Repligen (RGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·9d ago
News Placeholder
E. Ohman J or Asset Management AB Takes Position in Repligen Corporation $RGEN
E. Ohman J or Asset Management AB bought a new stake in shares of Repligen Corporation (NASDAQ:RGEN - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with...
MarketBeat·11d ago
News Placeholder
Repligen Corporation $RGEN Stock Position Raised by Congress Asset Management Co.
Congress Asset Management Co. grew its position in shares of Repligen Corporation (NASDAQ:RGEN - Free Report) by 241.4% in the 4th quarter, according to the company in its most recent filing with the...
MarketBeat·11d ago
News Placeholder
Repligen (NASDAQ:RGEN) Price Target Raised to $208.00
HC Wainwright lifted their price target on shares of Repligen from $180.00 to $208.00 and gave the company a "buy" rating in a report on Monday...
MarketBeat·12d ago
News Placeholder
Hudson Bay Capital Management LP Invests $2.81 Million in Repligen Corporation $RGEN
Hudson Bay Capital Management LP bought a new position in shares of Repligen Corporation (NASDAQ:RGEN - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 21,003 shares of the biotechnology...
MarketBeat·13d ago
News Placeholder
Repligen Conference: CEO touts differentiated bioprocessing portfolio; CFO targets 30% EBITDA margin
Repligen (NASDAQ:RGEN) executives outlined a strategy focused on portfolio breadth, innovation, and commercial execution during a recent discussion with Life Science Analyst Paul Knight. Chief...
MarketBeat·13d ago
News Placeholder
Alliancebernstein L.P. Buys 197,778 Shares of Repligen Corporation $RGEN
Alliancebernstein L.P. boosted its stake in shares of Repligen Corporation (NASDAQ:RGEN - Free Report) by 21.8% in the 3rd quarter, according to its most recent filing with the Securities and...
MarketBeat·18d ago
News Placeholder
270,000 Shares in Repligen Corporation $RGEN Acquired by Iron Triangle Partners LP
Iron Triangle Partners LP purchased a new stake in shares of Repligen Corporation (NASDAQ:RGEN - Free Report) during the third quarter, according to the company in its most recent 13F filing with the...
MarketBeat·19d ago
<
1
2
...
>

Latest RGEN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.